HomeKRK • WSE
Krka d.d. Novo Mesto
zł 608.00
Jul 2, 5:55:56 PM GMT+2 · PLN · WSE · Disclaimer
StockPL listed security
Previous close
zł 608.00
Day range
zł 606.00 - zł 612.00
Year range
zł 450.00 - zł 622.00
Avg Volume
90.00
P/E ratio
-
Dividend yield
-
CDP Climate Change Score
C
In the news
Financials
Income Statement
Revenue
Net income
(EUR)Mar 2024Y/Y change
Revenue
486.14M6.10%
Operating expense
165.75M3.92%
Net income
98.88M11.08%
Net profit margin
20.344.68%
Earnings per share
EBITDA
137.52M-5.32%
Effective tax rate
16.75%
Total assets
Total liabilities
(EUR)Mar 2024Y/Y change
Cash and short-term investments
563.62M-0.53%
Total assets
2.86B3.42%
Total liabilities
582.22M5.25%
Total equity
2.28B
Shares outstanding
30.82M
Price to book
8.31
Return on assets
10.16%
Return on capital
12.74%
Net change in cash
(EUR)Mar 2024Y/Y change
Net income
98.88M11.08%
Cash from operations
62.26M134.32%
Cash from investing
19.16M183.47%
Cash from financing
-8.83M-23.98%
Net change in cash
72.59M2,503.58%
Free cash flow
4.20M130.94%
About
Krka, d. d., Novo mesto is an international generic pharmaceutical company with headquarters in Novo Mesto, Slovenia. As well as a number of companies and representative offices abroad, Krka also had production and distribution centers in Russia, Poland, Croatia, and Germany. Krka sells products to more than 70 countries. In 2018, Krka Group's total sales amounted to 1.332 billion euros. Over the previous five years, average annual sales growth had been at 2.9% rate. At the end of 2018, Krka Group had 11,390 employees. Wikipedia
Founded
Apr 23, 1954
Website
Employees
12,675
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu